Aniscal, Jobert R.

HRN: 22-19-52  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/16/2022
CEFIXIME 100MG/5ML, 60ML SUSPENSION (BOT)
11/16/2022
11/21/2022
PO
3 Ml
Q12
PCAP
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: